Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.

Deftereos SN, Dodou E, Andronis C, Persidis A.

Expert Rev Clin Pharmacol. 2012 Jul;5(4):413-25. doi: 10.1586/ecp.12.29. Review.

PMID:
22943121
2.

The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10.

Agarwal P, Verzi MP, Nguyen T, Hu J, Ehlers ML, McCulley DJ, Xu SM, Dodou E, Anderson JP, Wei ML, Black BL.

Development. 2011 Jun;138(12):2555-65. doi: 10.1242/dev.056804.

3.

Ventralized zebrafish embryo rescue by overexpression of Zic2a.

Dodou E, Barald KF, Postlethwait JH.

Zebrafish. 2004;1(3):239-56. doi: 10.1089/zeb.2004.1.239.

4.

The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field.

Verzi MP, McCulley DJ, De Val S, Dodou E, Black BL.

Dev Biol. 2005 Nov 1;287(1):134-45. Epub 2005 Sep 26.

5.

Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development.

Dodou E, Verzi MP, Anderson JP, Xu SM, Black BL.

Development. 2004 Aug;131(16):3931-42. Epub 2004 Jul 14.

6.

HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.

Anderson JP, Dodou E, Heidt AB, De Val SJ, Jaehnig EJ, Greene SB, Olson EN, Black BL.

Mol Cell Biol. 2004 May;24(9):3757-68.

7.
8.

N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor.

Verzi MP, Anderson JP, Dodou E, Kelly KK, Greene SB, North BJ, Cripps RM, Black BL.

Dev Biol. 2002 Sep 1;249(1):174-90.

10.

MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells.

Dodou E, Sparrow DB, Mohun T, Treisman R.

Nucleic Acids Res. 1995 Nov 11;23(21):4267-74.

Supplemental Content

Support Center